English

Guardant Health, Inc.

EDGAR

GH Quarterly report (10-Q) · filed 2026-07-30

Annual consolidated revenue for 2025: about USD 982M, using the latest reported figures. The previous period, 2024, was about USD 739M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

335 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 334978000 USD Source

Operating margin

-38.55%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -129118000 USD Source
Revenue: 334978000 USD Source

Operating cash flow

-57.8 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -123401000 USD Source
Operating Cash Flow: -65623000 USD Source

Free cash flow

-69.5 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -123401000 USD Source
Operating Cash Flow: -65623000 USD Source
Capital Expenditure: 17339000 USD Source
Capital Expenditure: 5580000 USD Source

Cash and cash equivalents: 1.05 billion USD 2026-06-30 Source
Exact value

1053469000 USD
Long-term debt including current maturities: 1.5 billion USD 2026-06-30 Source
Exact value

1502943000 USD
Shares outstanding: 134 million shares 2026-06-30 Source
Exact value

133612678 shares

Reported share-count change

7.34% · 9.13 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

124477904 shares · 2025-06-30· Source
133612678 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.18 billion USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 265196000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 982021000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 700755000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 301665000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 334978000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-453 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -92725000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -416277000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -287783000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -112075000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -120142000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-185 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -158387000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -122974000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -184760000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -158387000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -65623000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -123401000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -65623000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

55.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 20458000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 10108000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 48306000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 20458000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5580000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 17339000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5580000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-241 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -158387000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -122974000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -184760000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -158387000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -65623000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -123401000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -65623000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 20458000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 10108000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 48306000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 20458000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 5580000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 17339000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 5580000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-07-30.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2025-12-31
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+32.9%

Prior period

USD 739.02 million

2024-01-01 – 2024-12-31
Current period

USD 982.02 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

982021000 − 739016000 = 243005000 USD

739016000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
982021000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Year-over-year change in Revenue: 243005000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 982021000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#2383087 Filing: 000157628026000013 Input fundies:Revenue: 739016000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#2384038 Filing: 000157628026000013
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 20.1 million

Prior period

−USD 436.37 million

2024-01-01 – 2024-12-31
Current period

−USD 416.28 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-416277000 − -436373000 = 20096000 USD

-436373000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-416277000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Year-over-year change in Net income: 20096000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -416277000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1357459 Filing: 000157628026000013 Input fundies:NetIncome: -436373000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1358255 Filing: 000157628026000013
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 55.1 million

Prior period

−USD 239.86 million

2024-01-01 – 2024-12-31
Current period

−USD 184.76 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-184760000 − -239858000 = 55098000 USD

-239858000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-184760000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Year-over-year change in Operating cash flow: 55098000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -184760000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1395372 Filing: 000157628026000013 Input fundies:OperatingCashFlow: -239858000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1396025 Filing: 000157628026000013
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+37.7%

Prior period

USD 35.09 million

2024-01-01 – 2024-12-31
Current period

USD 48.31 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

48306000 − 35085000 = 13221000 USD

35085000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
48306000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Year-over-year change in Capital expenditure: 13221000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 48306000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1406481 Filing: 000157628026000013 Input fundies:CapitalExpenditure: 35085000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1407072 Filing: 000157628026000013
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 982.02 million 100% of revenue
Operating costs Derived USD 1.42 billion 145% of revenue
Operating income −USD 437.25 million −45% of revenue
Tax, interest and other Derived −USD 20.97 million −2.1% of revenue
Net income −USD 416.28 million −42% of revenue

Cash

Operating cash flow −USD 184.76 million −19% of revenue
Capital expenditure USD 48.31 million 4.9% of revenue
Free cash flow Derived −USD 233.07 million −24% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 274% of revenue.
2017 Operating loss: operating costs were 254% of revenue.
2018 Operating loss: operating costs were 203% of revenue.
2019 Operating loss: operating costs were 138% of revenue.
2020 Not shown: operating income or net income is not reported.
2021 Operating loss: operating costs were 210% of revenue.
2022 Operating loss: operating costs were 221% of revenue.
2023 Operating loss: operating costs were 200% of revenue.
2024 Operating loss: operating costs were 160% of revenue.
2025 Operating loss: operating costs were 145% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	25249000	69096000 Derived	-43847000	2292000 Derived	-46139000	-38476000 Derived	Source 2016-01-01 – 2016-12-31: 25249000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -43847000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -46139000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -36710000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 1766000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	49842000	126454000 Derived	-76612000	6609000 Derived	-83221000	-78916000 Derived	Source 2017-01-01 – 2017-12-31: 49842000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -76612000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -83221000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -72235000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 6681000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	90639000	183581000 Derived	-92942000	-7879000 Derived	-85063000	-92388000 Derived	Source 2018-01-01 – 2018-12-31: 90639000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -92942000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -85063000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -72185000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 20203000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	214375000	296746000 Derived	-82371000	-6720000 Derived	-75651000	-65851000 Derived	Source 2019-01-01 – 2019-12-31: 214375000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -82371000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -75651000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -47134000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 18717000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	286730000	541680000 Derived	-254950000	Unavailable	Unavailable	-140100000 Derived	Source 2020-01-01 – 2020-12-31: 286730000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -254950000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -103927000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 36173000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	373653000	784654000 Derived	-411001000	-26231000 Derived	-384770000	-284052000 Derived	Source 2021-01-01 – 2021-12-31: 373653000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -411001000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -384770000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -209017000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 75035000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	449538000	993916000 Derived	-544378000	110210000 Derived	-654588000	-386924000 Derived	Source 2022-01-01 – 2022-12-31: 449538000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -544378000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -654588000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -309463000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 77461000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	563948000	1128673000 Derived	-564725000	-85276000 Derived	-479449000	-345461000 Derived	Source 2023-01-01 – 2023-12-31: 563948000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -564725000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -479449000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -324975000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 20486000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	739016000	1182610000 Derived	-443594000	-7221000 Derived	-436373000	-274943000 Derived	Source 2024-01-01 – 2024-12-31: 739016000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -443594000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -436373000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -239858000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 35085000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	982021000	1419269000 Derived	-437248000	-20971000 Derived	-416277000	-233066000 Derived	Source 2025-01-01 – 2025-12-31: 982021000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -437248000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -416277000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -184760000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 48306000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 982M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	25249000	Revenue: 25249000 Open source
20172017-12-31	Revenue	49842000	Revenue: 49842000 Open source
20182018-12-31	Revenue	90639000	Revenue: 90639000 Open source
20192019-12-31	Revenue	214375000	Revenue: 214375000 Open source
20202020-12-31	Revenue	286730000	Revenue: 286730000 Open source
20212021-12-31	Revenue	373653000	Revenue: 373653000 Open source
20222022-12-31	Revenue	449538000	Revenue: 449538000 Open source
20232023-12-31	Revenue	563948000	Revenue: 563948000 Open source
20242024-12-31	Revenue	739016000	Revenue: 739016000 Open source
20252025-12-31	Revenue	982021000	Revenue: 982021000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

32.9% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 25249000 Open source
20172017-12-31	Year over year	97.4%	Revenue: 49842000 Open source Revenue: 25249000 Open source
20182018-12-31	Year over year	81.9%	Revenue: 90639000 Open source Revenue: 49842000 Open source
20192019-12-31	Year over year	136.5%	Revenue: 214375000 Open source Revenue: 90639000 Open source
20202020-12-31	Year over year	33.8%	Revenue: 286730000 Open source Revenue: 214375000 Open source
20212021-12-31	Year over year	30.3%	Revenue: 373653000 Open source Revenue: 286730000 Open source
20222022-12-31	Year over year	20.3%	Revenue: 449538000 Open source Revenue: 373653000 Open source
20232023-12-31	Year over year	25.5%	Revenue: 563948000 Open source Revenue: 449538000 Open source
20242024-12-31	Year over year	31%	Revenue: 739016000 Open source Revenue: 563948000 Open source
20252025-12-31	Year over year	32.9%	Revenue: 982021000 Open source Revenue: 739016000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -44.5% 2025

Net margin -42.4% 2025

Free cash flow margin -23.7% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-173.7%	Operating Income: -43847000 Open source Revenue: 25249000 Open source
20172017-12-31	Operating margin	-153.7%	Operating Income: -76612000 Open source Revenue: 49842000 Open source
20182018-12-31	Operating margin	-102.5%	Operating Income: -92942000 Open source Revenue: 90639000 Open source
20192019-12-31	Operating margin	-38.4%	Operating Income: -82371000 Open source Revenue: 214375000 Open source
20202020-12-31	Operating margin	-88.9%	Operating Income: -254950000 Open source Revenue: 286730000 Open source
20212021-12-31	Operating margin	-110%	Operating Income: -411001000 Open source Revenue: 373653000 Open source
20222022-12-31	Operating margin	-121.1%	Operating Income: -544378000 Open source Revenue: 449538000 Open source
20232023-12-31	Operating margin	-100.1%	Operating Income: -564725000 Open source Revenue: 563948000 Open source
20242024-12-31	Operating margin	-60%	Operating Income: -443594000 Open source Revenue: 739016000 Open source
20252025-12-31	Operating margin	-44.5%	Operating Income: -437248000 Open source Revenue: 982021000 Open source
20162016-12-31	Net margin	-182.7%	Net Income: -46139000 Open source Revenue: 25249000 Open source
20172017-12-31	Net margin	-167%	Net Income: -83221000 Open source Revenue: 49842000 Open source
20182018-12-31	Net margin	-93.8%	Net Income: -85063000 Open source Revenue: 90639000 Open source
20192019-12-31	Net margin	-35.3%	Net Income: -75651000 Open source Revenue: 214375000 Open source
2020-12-31	Net margin	Not reported	Revenue: 286730000 Open source
20212021-12-31	Net margin	-103%	Net Income: -384770000 Open source Revenue: 373653000 Open source
20222022-12-31	Net margin	-145.6%	Net Income: -654588000 Open source Revenue: 449538000 Open source
20232023-12-31	Net margin	-85%	Net Income: -479449000 Open source Revenue: 563948000 Open source
20242024-12-31	Net margin	-59%	Net Income: -436373000 Open source Revenue: 739016000 Open source
20252025-12-31	Net margin	-42.4%	Net Income: -416277000 Open source Revenue: 982021000 Open source
20162016-12-31	Free cash flow margin	-152.4%	Revenue: 25249000 Open source Operating Cash Flow: -36710000 Open source Capital Expenditure: 1766000 Open source
20172017-12-31	Free cash flow margin	-158.3%	Revenue: 49842000 Open source Operating Cash Flow: -72235000 Open source Capital Expenditure: 6681000 Open source
20182018-12-31	Free cash flow margin	-101.9%	Revenue: 90639000 Open source Operating Cash Flow: -72185000 Open source Capital Expenditure: 20203000 Open source
20192019-12-31	Free cash flow margin	-30.7%	Revenue: 214375000 Open source Operating Cash Flow: -47134000 Open source Capital Expenditure: 18717000 Open source
20202020-12-31	Free cash flow margin	-48.9%	Revenue: 286730000 Open source Operating Cash Flow: -103927000 Open source Capital Expenditure: 36173000 Open source
20212021-12-31	Free cash flow margin	-76%	Revenue: 373653000 Open source Operating Cash Flow: -209017000 Open source Capital Expenditure: 75035000 Open source
20222022-12-31	Free cash flow margin	-86.1%	Revenue: 449538000 Open source Operating Cash Flow: -309463000 Open source Capital Expenditure: 77461000 Open source
20232023-12-31	Free cash flow margin	-61.3%	Revenue: 563948000 Open source Operating Cash Flow: -324975000 Open source Capital Expenditure: 20486000 Open source
20242024-12-31	Free cash flow margin	-37.2%	Revenue: 739016000 Open source Operating Cash Flow: -239858000 Open source Capital Expenditure: 35085000 Open source
20252025-12-31	Free cash flow margin	-23.7%	Revenue: 982021000 Open source Operating Cash Flow: -184760000 Open source Capital Expenditure: 48306000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -184.8M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-36710000	Operating Cash Flow: -36710000 Open source
20172017-12-31	Operating cash flow	-72235000	Operating Cash Flow: -72235000 Open source
20182018-12-31	Operating cash flow	-72185000	Operating Cash Flow: -72185000 Open source
20192019-12-31	Operating cash flow	-47134000	Operating Cash Flow: -47134000 Open source
20202020-12-31	Operating cash flow	-103927000	Operating Cash Flow: -103927000 Open source
20212021-12-31	Operating cash flow	-209017000	Operating Cash Flow: -209017000 Open source
20222022-12-31	Operating cash flow	-309463000	Operating Cash Flow: -309463000 Open source
20232023-12-31	Operating cash flow	-324975000	Operating Cash Flow: -324975000 Open source
20242024-12-31	Operating cash flow	-239858000	Operating Cash Flow: -239858000 Open source
20252025-12-31	Operating cash flow	-184760000	Operating Cash Flow: -184760000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -233.1M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-38476000	Operating Cash Flow: -36710000 Open source Capital Expenditure: 1766000 Open source
20172017-12-31	Free cash flow	-78916000	Operating Cash Flow: -72235000 Open source Capital Expenditure: 6681000 Open source
20182018-12-31	Free cash flow	-92388000	Operating Cash Flow: -72185000 Open source Capital Expenditure: 20203000 Open source
20192019-12-31	Free cash flow	-65851000	Operating Cash Flow: -47134000 Open source Capital Expenditure: 18717000 Open source
20202020-12-31	Free cash flow	-140100000	Operating Cash Flow: -103927000 Open source Capital Expenditure: 36173000 Open source
20212021-12-31	Free cash flow	-284052000	Operating Cash Flow: -209017000 Open source Capital Expenditure: 75035000 Open source
20222022-12-31	Free cash flow	-386924000	Operating Cash Flow: -309463000 Open source Capital Expenditure: 77461000 Open source
20232023-12-31	Free cash flow	-345461000	Operating Cash Flow: -324975000 Open source Capital Expenditure: 20486000 Open source
20242024-12-31	Free cash flow	-274943000	Operating Cash Flow: -239858000 Open source Capital Expenditure: 35085000 Open source
20252025-12-31	Free cash flow	-233066000	Operating Cash Flow: -184760000 Open source Capital Expenditure: 48306000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

104.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	No source recorded
20172017-12-31	Liabilities / assets	10%	Total Liabilities: 34332000 Open source Total Assets: 342938000 Open source
20182018-12-31	Liabilities / assets	10.6%	Total Liabilities: 62451000 Open source Total Assets: 587403000 Open source
20192019-12-31	Liabilities / assets	11.9%	Total Liabilities: 114542000 Open source Total Assets: 962535000 Open source
20202020-12-31	Liabilities / assets	40.3%	Total Liabilities: 916186000 Open source Total Assets: 2271781000 Open source
20212021-12-31	Liabilities / assets	70.7%	Total Liabilities: 1559494000 Open source Total Assets: 2204499000 Open source
20222022-12-31	Liabilities / assets	96.3%	Total Liabilities: 1549805000 Open source Total Assets: 1609985000 Open source
20232023-12-31	Liabilities / assets	91.1%	Total Liabilities: 1627737000 Open source Total Assets: 1786421000 Open source
20242024-12-31	Liabilities / assets	109.4%	Total Liabilities: 1625256000 Open source Total Assets: 1485609000 Open source
20252025-12-31	Liabilities / assets	104.9%	Total Liabilities: 2112966000 Open source Total Assets: 2013659000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.84× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
20172017-12-31	Current assets / current liabilities	12.38×	Current Assets: 242935000 Open source Current Liabilities: 19627000 Open source
20182018-12-31	Current assets / current liabilities	9.99×	Current Assets: 468991000 Open source Current Liabilities: 46944000 Open source
20192019-12-31	Current assets / current liabilities	8.21×	Current Assets: 597358000 Open source Current Liabilities: 72734000 Open source
20202020-12-31	Current assets / current liabilities	28.27×	Current Assets: 1888361000 Open source Current Liabilities: 66809000 Open source
20212021-12-31	Current assets / current liabilities	5.72×	Current Assets: 1114126000 Open source Current Liabilities: 194687000 Open source
20222022-12-31	Current assets / current liabilities	6.17×	Current Assets: 1191594000 Open source Current Liabilities: 193220000 Open source
20232023-12-31	Current assets / current liabilities	6.54×	Current Assets: 1347106000 Open source Current Liabilities: 205917000 Open source
20242024-12-31	Current assets / current liabilities	4.68×	Current Assets: 1055114000 Open source Current Liabilities: 225583000 Open source
20252025-12-31	Current assets / current liabilities	4.84×	Current Assets: 1466046000 Open source Current Liabilities: 302730000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 46.14 million Exact value Exact value: -46139000 USD 2016-01-01 – 2016-12-31: -46139000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2016-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -46139000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46139000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828019003139/gh-20181231.xml#332814 Filing: 000162828019003139 The citation records this snapshot. The page link may show a newer release later.	−USD 36.71 million Exact value Exact value: -36710000 USD 2016-01-01 – 2016-12-31: -36710000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2016-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -36710000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36710000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828019003139/gh-20181231.xml#332178 Filing: 000162828019003139 The citation records this snapshot. The page link may show a newer release later.	USD 1.77 million Exact value Exact value: 1766000 USD 2016-01-01 – 2016-12-31: 1766000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2016-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 1766000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1766000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828019003139/gh-20181231.xml#348602 Filing: 000162828019003139 The citation records this snapshot. The page link may show a newer release later.	−USD 38.48 million Calculation and evidence -36710000 − 1766000 USD Exact free cash flow: -38476000 USD 2016-01-01 – 2016-12-31: -36710000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 1766000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2016-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -38476000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36710000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828019003139/gh-20181231.xml#332178 Filing: 000162828019003139 Input fundies:CapitalExpenditure: 1766000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828019003139/gh-20181231.xml#348602 Filing: 000162828019003139 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 83.22 million Exact value Exact value: -83221000 USD 2017-01-01 – 2017-12-31: -83221000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2017-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -83221000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -83221000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#3037711 Filing: 000162828020002613 The citation records this snapshot. The page link may show a newer release later.	−USD 72.24 million Exact value Exact value: -72235000 USD 2017-01-01 – 2017-12-31: -72235000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2017-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -72235000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72235000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#2093180 Filing: 000162828020002613 The citation records this snapshot. The page link may show a newer release later.	USD 6.68 million Exact value Exact value: 6681000 USD 2017-01-01 – 2017-12-31: 6681000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2017-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 6681000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6681000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#2107533 Filing: 000162828020002613 The citation records this snapshot. The page link may show a newer release later.	−USD 78.92 million Calculation and evidence -72235000 − 6681000 USD Exact free cash flow: -78916000 USD 2017-01-01 – 2017-12-31: -72235000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 6681000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2017-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -78916000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -72235000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#2093180 Filing: 000162828020002613 Input fundies:CapitalExpenditure: 6681000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#2107533 Filing: 000162828020002613 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 85.06 million Exact value Exact value: -85063000 USD 2018-01-01 – 2018-12-31: -85063000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2018-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -85063000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -85063000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#3036700 Filing: 000162828020002613 The citation records this snapshot. The page link may show a newer release later.	−USD 72.19 million Exact value Exact value: -72185000 USD 2018-01-01 – 2018-12-31: -72185000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2018-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -72185000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -72185000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628021000031/gh-20201231.htm#1841812 Filing: 000157628021000031 The citation records this snapshot. The page link may show a newer release later.	USD 20.2 million Exact value Exact value: 20203000 USD 2018-01-01 – 2018-12-31: 20203000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2018-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 20203000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20203000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628021000031/gh-20201231.htm#1855228 Filing: 000157628021000031 The citation records this snapshot. The page link may show a newer release later.	−USD 92.39 million Calculation and evidence -72185000 − 20203000 USD Exact free cash flow: -92388000 USD 2018-01-01 – 2018-12-31: -72185000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 20203000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2018-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -92388000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -72185000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628021000031/gh-20201231.htm#1841812 Filing: 000157628021000031 Input fundies:CapitalExpenditure: 20203000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628021000031/gh-20201231.htm#1855228 Filing: 000157628021000031 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 75.65 million Exact value Exact value: -75651000 USD 2019-01-01 – 2019-12-31: -75651000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2019-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -75651000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -75651000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000162828020002613/gh-12312019x10k.htm#3035689 Filing: 000162828020002613 The citation records this snapshot. The page link may show a newer release later.	−USD 47.13 million Exact value Exact value: -47134000 USD 2019-01-01 – 2019-12-31: -47134000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2019-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -47134000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47134000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628022000015/gh-20211231.htm#1718081 Filing: 000157628022000015 The citation records this snapshot. The page link may show a newer release later.	USD 18.72 million Exact value Exact value: 18717000 USD 2019-01-01 – 2019-12-31: 18717000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2019-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 18717000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18717000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628022000015/gh-20211231.htm#1734781 Filing: 000157628022000015 The citation records this snapshot. The page link may show a newer release later.	−USD 65.85 million Calculation and evidence -47134000 − 18717000 USD Exact free cash flow: -65851000 USD 2019-01-01 – 2019-12-31: -47134000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 18717000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2019-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -65851000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47134000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628022000015/gh-20211231.htm#1718081 Filing: 000157628022000015 Input fundies:CapitalExpenditure: 18717000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628022000015/gh-20211231.htm#1734781 Filing: 000157628022000015 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	Unavailable Not reported for this period.	−USD 103.93 million Exact value Exact value: -103927000 USD 2020-01-01 – 2020-12-31: -103927000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2020-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -103927000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -103927000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628023000020/gh-20221231.htm#1690856 Filing: 000157628023000020 The citation records this snapshot. The page link may show a newer release later.	USD 36.17 million Exact value Exact value: 36173000 USD 2020-01-01 – 2020-12-31: 36173000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2020-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 36173000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36173000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628023000020/gh-20221231.htm#1704390 Filing: 000157628023000020 The citation records this snapshot. The page link may show a newer release later.	−USD 140.1 million Calculation and evidence -103927000 − 36173000 USD Exact free cash flow: -140100000 USD 2020-01-01 – 2020-12-31: -103927000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 36173000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2020-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -140100000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -103927000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628023000020/gh-20221231.htm#1690856 Filing: 000157628023000020 Input fundies:CapitalExpenditure: 36173000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628023000020/gh-20221231.htm#1704390 Filing: 000157628023000020 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 384.77 million Exact value Exact value: -384770000 USD 2021-01-01 – 2021-12-31: -384770000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2021-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -384770000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -384770000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628024000043/gh-20231231.htm#2245084 Filing: 000157628024000043 The citation records this snapshot. The page link may show a newer release later.	−USD 209.02 million Exact value Exact value: -209017000 USD 2021-01-01 – 2021-12-31: -209017000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2021-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -209017000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -209017000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628024000043/gh-20231231.htm#1413868 Filing: 000157628024000043 The citation records this snapshot. The page link may show a newer release later.	USD 75.04 million Exact value Exact value: 75035000 USD 2021-01-01 – 2021-12-31: 75035000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2021-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 75035000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 75035000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628024000043/gh-20231231.htm#1422759 Filing: 000157628024000043 The citation records this snapshot. The page link may show a newer release later.	−USD 284.05 million Calculation and evidence -209017000 − 75035000 USD Exact free cash flow: -284052000 USD 2021-01-01 – 2021-12-31: -209017000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 75035000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2021-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -284052000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -209017000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628024000043/gh-20231231.htm#1413868 Filing: 000157628024000043 Input fundies:CapitalExpenditure: 75035000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628024000043/gh-20231231.htm#1422759 Filing: 000157628024000043 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 654.59 million Exact value Exact value: -654588000 USD 2022-01-01 – 2022-12-31: -654588000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2022-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -654588000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -654588000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm#1341971 Filing: 000157628025000044 The citation records this snapshot. The page link may show a newer release later.	−USD 309.46 million Exact value Exact value: -309463000 USD 2022-01-01 – 2022-12-31: -309463000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2022-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -309463000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -309463000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm#1382302 Filing: 000157628025000044 The citation records this snapshot. The page link may show a newer release later.	USD 77.46 million Exact value Exact value: 77461000 USD 2022-01-01 – 2022-12-31: 77461000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2022-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 77461000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 77461000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm#1393393 Filing: 000157628025000044 The citation records this snapshot. The page link may show a newer release later.	−USD 386.92 million Calculation and evidence -309463000 − 77461000 USD Exact free cash flow: -386924000 USD 2022-01-01 – 2022-12-31: -309463000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 77461000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2022-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -386924000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -309463000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm#1382302 Filing: 000157628025000044 Input fundies:CapitalExpenditure: 77461000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm#1393393 Filing: 000157628025000044 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 479.45 million Exact value Exact value: -479449000 USD 2023-01-01 – 2023-12-31: -479449000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2023-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -479449000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -479449000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1358952 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	−USD 324.98 million Exact value Exact value: -324975000 USD 2023-01-01 – 2023-12-31: -324975000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2023-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -324975000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -324975000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1396678 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	USD 20.49 million Exact value Exact value: 20486000 USD 2023-01-01 – 2023-12-31: 20486000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2023-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 20486000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20486000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1407663 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	−USD 345.46 million Calculation and evidence -324975000 − 20486000 USD Exact free cash flow: -345461000 USD 2023-01-01 – 2023-12-31: -324975000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 20486000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2023-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -345461000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -324975000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1396678 Filing: 000157628026000013 Input fundies:CapitalExpenditure: 20486000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1407663 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 436.37 million Exact value Exact value: -436373000 USD 2024-01-01 – 2024-12-31: -436373000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2024-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -436373000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -436373000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1358255 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	−USD 239.86 million Exact value Exact value: -239858000 USD 2024-01-01 – 2024-12-31: -239858000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2024-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -239858000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -239858000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1396025 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	USD 35.09 million Exact value Exact value: 35085000 USD 2024-01-01 – 2024-12-31: 35085000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2024-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 35085000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35085000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1407072 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	−USD 274.94 million Calculation and evidence -239858000 − 35085000 USD Exact free cash flow: -274943000 USD 2024-01-01 – 2024-12-31: -239858000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 35085000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2024-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -274943000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -239858000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1396025 Filing: 000157628026000013 Input fundies:CapitalExpenditure: 35085000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1407072 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 416.28 million Exact value Exact value: -416277000 USD 2025-01-01 – 2025-12-31: -416277000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Net Income: -416277000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -416277000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1357459 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	−USD 184.76 million Exact value Exact value: -184760000 USD 2025-01-01 – 2025-12-31: -184760000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Operating Cash Flow: -184760000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -184760000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1395372 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	USD 48.31 million Exact value Exact value: 48306000 USD 2025-01-01 – 2025-12-31: 48306000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Capital Expenditure: 48306000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48306000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1406481 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.	−USD 233.07 million Calculation and evidence -184760000 − 48306000 USD Exact free cash flow: -233066000 USD 2025-01-01 – 2025-12-31: -184760000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 48306000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Guardant Health, Inc. · 2025-12-31 Guardant Health, Inc. (edgar:1576280) Free cash flow: -233066000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:16:38Z Snapshot: 1db183c04d2ba4d0ff4065933a71ae8825a77cc9a84e8c581a40781f9b063c64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1576280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -184760000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1395372 Filing: 000157628026000013 Input fundies:CapitalExpenditure: 48306000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm#1406481 Filing: 000157628026000013 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

95 filings · 2,832 latest values · 2,832 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001576280, 1576280, GH, edgar:1576280

Also known as GUARDANT HEALTH, INC., Guardant Health, Inc.

Guardant Health, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation